Research Fellow
Mayo Clinic
Dr. Min Wang, MD, earned his MD from China. After 3 years research training in a lab of cardiac functional studies at University of Cincinnati, he joined Dr. Richard Weinshilboum and Dr. Naveen Pereira (cardiology clinician) joint lab and started his research training in cardiovascular pharmacogenomics studies. Started from Feb 2023, he has been selected as a NIH funded clinical pharmacology T32 awardee. His research work has been published on high imacpt factor journals, such as Circulation Research, Circulation Heart Failure. He also has presented his research work at international scientific meetings, such as annal meetings of American Heart Association (AHA), European Society of Cardiology (ESC) and American College of Cardiology (ACC) and ASCPT. Dr. Wang continues working on several pharmacogenomic research projects to identify biomarkers and pharmaco-therapeutic strategies for heart failure.